CHA sent a comment letter to the FDA on draft guidance that recommends how and when manufacturers provide additional information in drug shortage notifications to the agency. Our letter urges the FDA to address the specific challenges facing the pediatric drug supply chain through transparency requirements, developing proactive shortage mitigation plans, and ensuring an accounting of pediatric drugs on the FDA drug shortages list.
CHA Submits Comments on FDA Drug Shortage Guidance
Children’s Hospital Association sends a comment letter to the FDA on draft drug shortage guidance to highlight the need for an efficient pediatric supply chain.
Related Content
Why Global Collaboration Matters to Children's Health
CHA Launches Six-Figure Ad Campaign Calling for Congress to Protect Medicaid
Co-sponsor the Accelerating Kids' Access to Care Act
Why Global Collaboration Matters to Children's Health
By listening, learning, and advocating together, we can make sure all children get the care they need to thrive.
April 15, 2025
CHA Launches Six-Figure Ad Campaign Calling for Congress to Protect Medicaid
The digital ads will appear in Washington D.C., Maryland, and Virginia with TV spots to follow.
April 01, 2025
Co-sponsor the Accelerating Kids' Access to Care Act
Ask your lawmakers to co-sponsor the Accelerating Kids' Access to Care Act and improve children's timely access to essential health care.
April 01, 2025
